Jackson and Sharpton Silent on #CDCWhistleblower

We told you recently about a new whistleblower inside the CDC, Doctor William Thompson. Thompson says he stayed quiet for over 10 years after finding a link between vaccines in young black children and autism. Thompson also says the CDC knew about this link, and purposely manipulated the evidence to remove “Black Babies without birth certificates” from the study. The initial report showed a 340 percent increase in autism among black boys under 36 months old.

In a carefully worded statement, the CDC clearly admitted they “DID NOT present data, because the children without birth certificates lacked meta data on risk factors – including Race.”

In years past, activists Al Sharpton and Jesse Jackson have gone toe-to-toe with agencies and organizations all over the country. But this time, at least for now, they are strangely quiet.

While both men have been busy in Ferguson Missouri for the shooting death of one man, this new report indicts the Federal Government of shooting thousands of black babies with a dangerous vaccination.

Instead of staying true to their cause, defending civil liberties for Americans of African descent, the two men are nowhere to be found in this egregious act targeting young black babies.

Sharpton and Jackson have both raised millions of dollars and garnered countless votes for Barack Obama in his two presidential elections. Maybe now, they are afraid to speak out with anything that could potentially call his administration into question.

With a big Congressional election just around the corner, you can bet the Democratic Convention would spend big money to keep Sharpton and Jackson from upsetting the ongoing campaign. Any shred of anti-Obama sentiment could trickle down into the ballot box on the state or local level.

There isn’t any evidence to prove Sharpton or Jackson struck a deal to keep quiet, but with this new report about the CDC airing on national television, there is no way they can afford to stay silent AND keep the trust of their audience.